MS

Sanofi MS drug nears green light after pass-the-parcel marathon

Sanofi MS drug nears green light after pass-the-parcel marathon

Reuters

Biogen MS drug scripts up 12% in week eight, says Citigroup

Biogen MS drug scripts up 12% in week eight, says Citigroup

The Fly on the Wall

FDA Accepts Teva sNDA - Analyst Blog

FDA Accepts Teva sNDA - Analyst Blog

NASDAQ

Biogen’s MS Pill Delayed in Europe as Patent Extended

Biogen’s MS Pill Delayed in Europe as Patent Extended

Bloomberg

Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It

Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It

Forbes

Biogen Idec submits Plegridy to FDA for multiple sclerosis patients with relapsed disease

Biogen Idec submits Plegridy to FDA for multiple sclerosis patients with relapsed disease

Yahoo/AP

XenoPort Sinks as Spasticity Drug For MS Fails in Trial

XenoPort Sinks as Spasticity Drug For MS Fails in Trial

Bloomberg

The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?

The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?

Pharmalot

Biogen MS Pill’s Early Sales May Help It Beat Estimates

Biogen MS Pill’s Early Sales May Help It Beat Estimates

Bloomberg

Biogen's MS Pill Roars Out Of Launch Gate

Biogen's MS Pill Roars Out Of Launch Gate

TheStreet.com